|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rupaimoole R and Slack FJ: MicroRNA
therapeutics: Towards a new era for the management of cancer and
other diseases. Nat Rev Drug Discov. 16:203–222. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu D, Li Y, Luo G, Xiao X, Tao D, Wu X,
Wang M, Huang C, Wang L, Zeng F and Jiang G: LncRNA SPRY4-IT1
sponges miR-101-3p to promote proliferation and metastasis of
bladder cancer cells through up-regulating EZH2. Cancer Lett.
388:281–291. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Qian K, Liu G, Tang Z, Hu Y, Fang Y, Chen
Z and Xu X: The long non-coding RNA NEAT1 interacted with miR-101
modulates breast cancer growth by targeting EZH2. Arch Biochem
Biophys. 615:1–9. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu Y, Tan J, Ou S, Chen J and Chen L:
MicroRNA-101-3p suppresses proliferation and migration in
hepatocellular carcinoma by targeting the HGF/c-Met pathway. Invest
New Drugs. Mar 30–2019.(Epub ahead of print). doi:
10.1007/s10637-019-00766-8.
|
|
7
|
Chen LG, Xia YJ and Cui Y: Upregulation of
miR-101 enhances the cytotoxic effect of anticancer drugs through
inhibition of colon cancer cell proliferation. Oncol Rep.
38:100–108. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hattori M and Minato N: Rap1 GTPase:
Functions, regulation, and malignancy. J Biochem. 134:479–484.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pei W, Tao L, Zhang LW, Zhang S, Cao J,
Jiao Y, Tong J and Nie J: Circular RNA profiles in mouse lung
tissue induced by radon. Environ Health Prev Med. 22:362017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang Y, Li M, Yan Y, Zhang J, Sun K, Qu
JK, Wang JS and Duan XY: Expression of RAP1B is associated with
poor prognosis and promotes an aggressive phenotype in gastric
cancer. Oncol Rep. 34:2385–2394. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lin KT, Yeh YM, Chuang CM, Yang SY, Chang
JW, Sun SP, Wang YS, Chao KC and Wang LH: Glucocorticoids mediate
induction of microRNA-708 to suppress ovarian cancer metastasis
through targeting Rap1B. Nat Commun. 6:59172015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Huk DJ, Ashtekar A, Magner A, La Perle K
and Kirschner LS: Deletion of Rap1b, but not Rap1a or Epac1,
reduces protein kinase A-mediated thyroid cancer. Thyroid.
28:1153–1161. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tang Z, Peng H, Chen J, Liu Y, Yan S, Yu
G, Chen Q, Tang H and Liu S: Rap1b enhances the invasion and
migration of hepatocellular carcinoma cells by up-regulating Twist
1. Exp Cell Res. 367:56–64. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jia Z, Yang Y, Dengyan Z, Chunyang Z,
Donglei L, Kai W and Song Z: RAP1B, a DVL2 binding protein,
activates Wnt/beta-catenin signaling in esophageal squamous cell
carcinoma. Gene. 611:15–20. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li Z, Xu C, Ding B, Gao M, Wei X and Ji N:
Long non-coding RNA MALAT1 promotes proliferation and suppresses
apoptosis of glioma cells through derepressing Rap1B by sponging
miR-101. J Neurooncol. 134:19–28. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sheng Y, Ding S, Chen K, Chen J, Wang S,
Zou C, Zhang J, Cao Y, Huang A and Tang H: Functional analysis of
miR-101-3p and Rap1b involved in hepatitis B virus-related
hepatocellular carcinoma pathogenesis. Biochem Cell Biol.
92:152–162. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Joseph JV, Conroy S, Pavlov K, Sontakke P,
Tomar T, Eggens-Meijer E, Balasubramaniyan V, Wagemakers M, den
Dunnen WF and Kruyt FA: Hypoxia enhances migration and invasion in
glioblastoma by promoting a mesenchymal shift mediated by the
HIF1α-ZEB1 axis. Cancer Lett. 359:107–116. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Collins FS and Barker AD: Mapping the
cancer genome. Pinpointing the genes involved in cancer will help
chart a new course across the complex landscape of human
malignancies. Sci Am. 296:50–57. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li L, Zhu Z, Zhao Y, Zhang Q, Wu X, Miao
B, Cao J and Fei S: FN1, SPARC, and SERPINE1 are highly expressed
and significantly related to a poor prognosis of gastric
adenocarcinoma revealed by microarray and bioinformatics. Sci Rep.
9:78272019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hassanlou M, Soltani BM, Medlej A, Kay M
and Mowla SJ: Hsa-miR-6165 downregulates insulin-like growth
factor-1 receptor (IGF-1R) expression and enhances apoptosis in
SW480 cells. Biol Chem. Nov 8–2019.(Epub ahead of print). doi:
10.1515/hsz-2018-0421.
|
|
22
|
Zhu QL, Zhan DM, Chong YK, Ding L and Yang
YG: MiR-652-3p promotes bladder cancer migration and invasion by
targeting KCNN3. Eur Rev Med Pharmacol Sci. 23:8806–8812.
2019.PubMed/NCBI
|
|
23
|
Cao C, Xu Y, Du K, Mi C, Yang C, Xiang L,
Xie Y and Liu W: LINC01303 functions as a competing endogenous RNA
to regulate EZH2 expression by sponging miR-101-3p in gastric
cancer. J Cell Mol Med. 23:7342–7348. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang H, Wang X, Hu B, Zhang F, Wei H and
Li L: Circular RNA ZFR accelerates non-small cell lung cancer
progression by acting as a miR-101-3p sponge to enhance CUL4B
expression. Artif Cells Nanomed Biotechnol. 47:3410–3416. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu C, Sun Y, She X, Tu C, Cheng X, Wang
L, Yu Z, Li P, Liu Q, Yang H, et al: CASC2c as an unfavorable
prognosis factor interacts with miR-101 to mediate astrocytoma
tumorigenesis. Cell Death Dis. 8:e26392017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jiang M, Xu B, Li X, Shang Y, Chu Y, Wang
W, Chen D, Wu N, Hu S, Zhang S, et al: O-GlcNAcylation promotes
colorectal cancer metastasis via the miR-101-O-GlcNAc/EZH2
regulatory feedback circuit. Oncogene. 38:301–316. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xiong WC, Han N, Wu N, Zhao KL, Han C,
Wang HX, Ping GF, Zheng PF, Feng H, Qin L and He P: Interplay
between long noncoding RNA ZEB1-AS1 and miR-101/ZEB1 axis regulates
proliferation and migration of colorectal cancer cells. Am J Transl
Res. 10:605–617. 2018.PubMed/NCBI
|
|
28
|
Wilson JM, Lorimer E, Tyburski MD and
Williams CL: β-Adrenergic receptors suppress Rap1B prenylation and
promote the metastatic phenotype in breast cancer cells. Cancer
Biol Ther. 16:1364–1374. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang M, Zhou S, Zhang L, Zhang J, Cai H,
Zhu J, Huang C and Wang J: miR-518b is down-regulated, and involved
in cell proliferation and invasion by targeting Rap1b in esophageal
squamous cell carcinoma. FEBS Lett. 586:3508–3521. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li Y, Liu Y, Shi F, Cheng L and She J:
Knockdown of Rap1b enhances apoptosis and autophagy in gastric
cancer cells via the PI3K/Akt/mTOR pathway. Oncol Res. 24:287–293.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Peng H, Luo J, Hao H, Hu J, Xie SK, Ren D
and Rao B: MicroRNA-100 regulates SW620 colorectal cancer cell
proliferation and invasion by targeting RAP1B. Oncol Rep.
31:2055–2062. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Guo H, Hu X, Ge S, Qian G and Zhang J:
Regulation of RAP1B by miR-139 suppresses human colorectal
carcinoma cell proliferation. Int J Biochem Cell Biol.
44:1465–1472. 2012. View Article : Google Scholar : PubMed/NCBI
|
